131 related articles for article (PubMed ID: 270389)
1. A phase 1 and 2 trial of rubidazone in patients with acute leukemia.
Benjamin RS; Keating MJ; McCredie KB; Bodey GP; Freireich EJ
Cancer Res; 1977 Dec; 37(12):4623-8. PubMed ID: 270389
[No Abstract] [Full Text] [Related]
2. [57 cases of acute leukemia. Trial treatment with a semisynthetic daunorubicin derivative: 22,050 R.P].
Bernard J; Jacquillat C; Boiron M; Weil M; Gémon MF; Izrael V; Schaison G; Delobel J
Nouv Presse Med; 1972 Sep; 1(33):2149-52. PubMed ID: 4507740
[No Abstract] [Full Text] [Related]
3. Rubidazone in adults with previously treated acute leukemia and blast cell phase of chronic myelocytic leukemia: a Southwest Oncology Group Study.
Bickers J; Benjamin R; Wilson H; Eyre H; Hewlett J; McCredie K
Cancer Treat Rep; 1981; 65(5-6):427-30. PubMed ID: 6940659
[TBL] [Abstract][Full Text] [Related]
4. Daunorubicin (NSC-83142) in advanced childhood leukemia.
Jaffe N; Traggis DG; Das L
Cancer Chemother Rep; 1974; 58(5 Pt 1):661-5. PubMed ID: 4529663
[No Abstract] [Full Text] [Related]
5. [Effect of daunomycin and adriamycin in cytostatic combination therapy of acute leukoses of the adult].
Stacher A; Böhnel J; Höcker P
Med Klin; 1972 Aug; 67(31):1018-23. PubMed ID: 4506639
[No Abstract] [Full Text] [Related]
6. Phase II trial of vindesine in patients with acute leukemia.
Sklaroff RB; Arlin Z; Young CW
Cancer Treat Rep; 1979; 63(11-12):2063-5. PubMed ID: 294307
[TBL] [Abstract][Full Text] [Related]
7. Randomized phase II trial of rubidazone and adriamycin in women with advanced breast cancer.
Ingle JN; Ahmann DL; O'Fallon JR; Bisel HF; Rubin J; Kvols LK; Giuliani ER
Cancer Treat Rep; 1979; 63(11-12):1701-5. PubMed ID: 526908
[TBL] [Abstract][Full Text] [Related]
8. [Trial of adriamycin in the treatment of acute leukemia].
Mathé G; Amiel JL; Hayat M; de Vassal F; Schwarzenberg L; Schneider M; Jasmin C; Rosenfeld C
Presse Med (1893); 1970 Oct; 78(46):1997-9. PubMed ID: 5274058
[No Abstract] [Full Text] [Related]
9. [Acute lymphatic leukemia in adults. Therapy and prognosis in comparison with acute myelogenous leukemia].
Abbrederis K; Michlmayr G; Schmalzl F
Med Klin; 1974 Mar; 69(10):427-31. PubMed ID: 4524609
[No Abstract] [Full Text] [Related]
10. [Carminomycin in the therapy of leukemias].
Vygovskaia IaI; Mazurok AA; Kondrat'eva NA; Orel VG
Antibiotiki; 1982 Aug; 27(8):632-5. PubMed ID: 6957161
[No Abstract] [Full Text] [Related]
11. Treatment of acute leukemia in adults. Results with a combination of potent cytotoxic drugs.
Stavem P; Gjemdal T
Acta Med Scand; 1974; 196(1-2):121-5. PubMed ID: 4529548
[No Abstract] [Full Text] [Related]
12. Clinical studies with rubidazone.
Benjamin RS; Keating MJ; Swenerton KD; Legha S; McCredie KB
Cancer Treat Rep; 1979 May; 63(5):925-9. PubMed ID: 287557
[TBL] [Abstract][Full Text] [Related]
13. Time relationship between last dose of daunorubicin and congestive heart failure.
Von Hoff DD; Layard M; Rozencweig M; Muggia FM
Cancer Treat Rep; 1977 Oct; 61(7):1411-3. PubMed ID: 271046
[No Abstract] [Full Text] [Related]
14. [Use of carminomycin on adult patients with acute leukemias].
Faĭnshteĭn FE; Kovaleva LG; Vakhrusheva MV; Isaev VG; Abakumov EM
Antibiotiki; 1977 Aug; 22(8):756-8. PubMed ID: 334058
[TBL] [Abstract][Full Text] [Related]
15. The effect of thioguanine on a combination of daunorubicine, cytarabine and prednisone in the treatment of acute leukaemia in adults. The Finnish Leukaemia Group.
Scand J Haematol; 1979 Aug; 23(2):124-8. PubMed ID: 291122
[TBL] [Abstract][Full Text] [Related]
16. In vitro sensitivity of leukemic clonogenic cells to four anthracyclines (adriamycin, daunorubicin, rubidazone and aclacinomycin) in human acute myeloid leukemia.
Marie JP; Thevenin D; Zittoun R
Nouv Rev Fr Hematol (1978); 1985; 27(3):163-7. PubMed ID: 3862071
[TBL] [Abstract][Full Text] [Related]
17. [Clinical trial of daunomycin in acute leukemia in adults].
Martelli MF; Tonato M; Soldani M; Grignani F
Clin Ter; 1972 Jan; 60(2):149-58. PubMed ID: 4501941
[No Abstract] [Full Text] [Related]
18. [Cardiotoxic aspects of daunorubicin used in the treatment of acute myeloblastic and lymphoblastic leukoses].
Topalov V; Popović K; Cikos J; Pejin D; Uzurov V
Med Pregl; 1981; 34(3-4):119-22. PubMed ID: 6944597
[No Abstract] [Full Text] [Related]
19. [Therapy of acute leukemia. 4. Remission induction and remission maintenance therapy].
Hirano M; Uetani T; Morita A; Sako F; Koie K
Saishin Igaku; 1971 Oct; 26(10):2034-41. PubMed ID: 5288692
[No Abstract] [Full Text] [Related]
20. [Quality of survival in patients with acute leukemia subjected to combination drug therapy].
Almici C; Inzoli MR
G Clin Med; 1976; 57(5-6):183-91. PubMed ID: 1070454
[No Abstract] [Full Text] [Related]
[Next] [New Search]
